Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women. [electronic resource]
Producer: 20090213Description: 2445-9 p. digitalISSN:- 0263-6352
- Adiponectin -- metabolism
- Antihypertensive Agents -- pharmacology
- Atenolol -- pharmacology
- C-Reactive Protein -- metabolism
- Double-Blind Method
- Female
- Finland
- Humans
- Hypertension -- complications
- Imidazoles -- pharmacology
- Inflammation -- blood
- Insulin Resistance -- physiology
- Interleukin-6 -- blood
- Lithuania
- Middle Aged
- Overweight -- metabolism
- Postmenopause -- physiology
- Prospective Studies
- Receptors, Tumor Necrosis Factor, Type II -- blood
- Sweden
- Sympathetic Nervous System -- drug effects
- Tumor Necrosis Factor-alpha -- blood
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.